Combination value of cell index, CSF PCT, and CSF IL-6 for intracranial infection diagnosis after neurosurgery

C Caimu Wang Y Yiping Zhou C Chao Zhong H Hui Shan P Ping Wang Z Zisheng Ge Y Yushi Fan X Xinyun Zhang (Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences) K Kai Zhang Y Yesong Wang W Wei Cui (Department of Pharmacology, School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University) L Linlin Du Q Qijiang Chen G Gensheng Zhang

Abstract

Abstract This study evaluated the predictive value of cell index (CI), cerebrospinal fluid procalcitonin (CSF PCT), and cerebrospinal fluid interleukin-6 (CSF IL-6) for detecting intracranial infection after neurosurgery. A two-center, prospective study analyzed CSF samples from ICU patients suspected of having intracranial infection following neurosurgery from January 2020 to June 2023. Patients with infection had longer operation times and longer stays in the ICU. The AUCs for single biomarkers ranged from 0.829 to 0.860, with the highest AUC of 0.938 observed for the combined biomarkers CI + CSF PCT + CSF IL-6. CI was most effective in patients with elevated CSF RBC counts, and PCT was most effective for detecting Gram-negative infections. The combined use of these biomarkers enhances early diagnosis of intracranial infection after neurosurgery and warrants further study.

Article Details

Volume / Issue Vol. 15, Issue 1
Published April 13, 2025
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (14)

C

Caimu Wang

Y

Yiping Zhou

C

Chao Zhong

H

Hui Shan

P

Ping Wang

Z

Zisheng Ge

Y

Yushi Fan

X

Xinyun Zhang

Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences

K

Kai Zhang

Y

Yesong Wang

W

Wei Cui

Department of Pharmacology, School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University

L

Linlin Du

Q

Qijiang Chen

G

Gensheng Zhang